Decrease of (+)-3-[125I]MK-801 binding to NMDA brain receptors revealed at puberty in rats treated neonatally with monosodium glutamate

Developmental Brain Research

Volumn 95, Issue 2, 1996, Pages 149-156

  Otoya, Raúl Enrique ^a   Seltzer, Alicia Mabel ^a   Donoso, Alfredo Osvaldo ^a  

^a LINCE CONICET   (Argentina)

Author keywords

(+) 3 125I MK 801 binding; Cerebral cortex; Hippocampus; Hypothalamus; Monosodium glutamate; NMDA receptor

Indexed keywords

DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; DIAGNOSTIC AGENT; DIZOCILPINE MALEATE; GLUTAMATE SODIUM; RADIOACTIVE IODINE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; BRAIN DEVELOPMENT; CONTROLLED STUDY; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; ANIMAL; BRAIN; DRUG EFFECT; METABOLISM; PHYSIOLOGY; RADIOASSAY; SEXUAL MATURATION; SPRAGUE DAWLEY RAT;

ANIMALIA; RODENTIA;

ANIMALS; ANIMALS, NEWBORN; AUTORADIOGRAPHY; BRAIN; DIZOCILPINE MALEATE; HYPOTHALAMUS; IODINE RADIOISOTOPES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SEXUAL MATURATION; SODIUM GLUTAMATE;

EID: 0030565492     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(96)00082-X     Document Type: Article

References (35)

1. [1] Brann, D.W. and Mahesh, V.B., Excitatory amino acids: Function and significance in reproduction and neuroendocrine regulation, Frontiers Neuroendocrinol., 15 (1994) 3-49.
2. [2] Bourguignon, J.P., Gerard, A., Alvarez Gonzalez, M.L. and Franchimont, P., Control of pulsatile secretion of gonadotrophin releasing hormone from hypothalamic expiants, Hum. Reprod., 8 (1993) 18-22.
3. [3] Dawson, R., Valdes, J.J. and Annau, Z., Tuberohypophyseal and tuberoinfundibular dopamine systems exhibit differential sensitivity to neonatal monosodium glutamate treatment, Pharmacology, 31 (1985) 17-23.
4. [4] Dawson, R. Jr., Developmental and sex-specific effects of low dose neonatal monosodium glutamate administration on mediobasal hypothalamic chemistry, Neuroendocrinology, 42 (1986) 158-166.
5. [5] Desjardins, G.C., Brawer, J.R. and Beaudet, A., Monosodium glutamate-induced reductions in hypothalamic beta-endorphin content result in mu-opioid receptor upregulation in the medial preoptic area, Neuroendocrinology, 56 (1992) 378-384.
6. [6] Donoso, A.O., Seltzer, A.M., Navarro, C.E., Cabrera, R.J., Lopez, F.J. and Negro-Vilar, A., Regulation of luteinizing hormone-releasing hormone and luteinizing hormone secretion by hypothalamic amino acids, Brazil. J. Med. Biol. Res., 27 (1994) 921-932.
7. [7] Elefthereiou, B.E., El sistema límbico y los procesos neuroendócrinos. In O. Schiaffini, A. Oriol Bosch, L. Martini and M. Motta (Eds.), Neuroendocrinología, Toray, Barcelona, 1975, pp. 315-351.
8. [8] Farooqui, A.A. and Horrocks, L.A., Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders, Brain Res. Rev., 16 (1991) 171-191.
9. [9] Fisher, K.N., Turner, R.A., Pineault, G., Kleim, J. and Saari, M.J., The postweaning housing environment determines expression of learning deficit associated with neonatal monosodium glutamate (MGS), Neurotoxicol. Teratol., 13 (1991) 507-513.
10. [10] Isaacson, R.L., The structure of the Limbic system. In The Limbic System, Plenum Press, New York, 1982, pp. 1-60.
11. 125I]iodo-MK-801 binding to thin sections of rat brain, J. Neurosci. Methods, 46 (1993) 17-27.
12. [12] Johnston, C.A., Spinedi, E.J. and Negro-Vilar, A., Effects of neonatal monosodium glutamate (MSG) treatment on the hormonal and central monoaminergic dynamics associated with acute ether stress in the male rat, Brain Res. Bull., 13 (1984) 643-649.
13. [13] Kawakami, M., Seto, K. and Yoshida, K., Influence of the limbic system on ovulation and on progesterone and estrogen formation in rabbit's ovary, Jap. J. Physiol., 16 (1966) 254.
14. [14] Kubo, T., Kohira, R., Okano, T. and Ishikawa, K., Neonatal glutamate can destroy the hippocampal CA1 structure and impair discrimination learning in rats, Brain Res., 616 (1993) 311-314.
15. 125I]MK-801 binding in the hypothalamus of intact, castrate and castrate-DHTP treated male rats, Mol. Brain Res., 28 (1995) 55-60.
16. [16] MacDonald, M.C. and Wilkinson, M., Peripubertal treatment with N-methyl-D-aspartic acid or neonatally with monosodium glutamate accelerates sexual maturation in female rats, and effect reversed by MK-801, Neuroendocrinology, 52 (1990) 143-149.
17. [17] Marrosu, F., Argiolas, A., Carcangiu. P., Giagheddu, M. and Fratta, W., Neonatal monosodium glutamate abolishes corticotropin-releasing factor-induced epileptogenic activity in rats, Epilepsia, 31 (1990) 708-712.
18. [18] McDonald, J. and Johnston, M., Physiological and pathophysiological roles of excitatory amino acids during central nervous system development, Brain Res. Rev., 15 (1990) 41-70.
19. [19] Meeker, R.B., Greenwood, R.S. and Hayward, J.N., Glutamate receptors in the rat hypothalamus and pituitary, Endocrinology, 134 (1994) 621-629.
20. [20] Meister, B., Ceccatelli, S., Hökfelt, T., Anden, N.-E., Anden, M. and Theodorsson, E., Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions, Exp. Brain Res., 76 (1989) 343-368.
21. 125I-polymer standards with 1251-brain paste standards for use in quantitative receptor autoradiography, J. Neurosci. Methods, 30 (1989) 247-253.
22. [22] Nemeroff, C.B., Konkol, R.J., Bissette, G., Youngblood, W., Martin, J., Brazeau, P., Rone, M.S., Prange, A.J., Breese, G.R. and Kizer, J., Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium L-glutamate (MSG): Evidence for the involvement of tuberoinfundibular cholinergic and dopaminergic systems in neuroendocrine regulation, Endocrinology, 101 (1977) 613-622.
23. [23] Olney, J.W., Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate, Science, 164 (1969) 719-721.
24. [24] Olney, J.W., Excitotoxic amino acids and neuropsychiatric disorders, Annu. Rev. Pharmacol. Toxicol., 30 (1995) 47-71.
25. [25] Olney, J.W. and Price, M.T., Neuroendocrine interactions of excitatory and inhibitory amino acids, Brain Res. Bull., 5 (Suppl. 2) (1980) 361-368.
26. [26] Otoya, R.E., Muñoz, V. and Donoso, A.O., Prepubertal disfunction of the LHRH/LH axis in monosodium glutamate (MSG)-treated rats revealed by the LH response to N-methyl-D-aspartate, Neuroendocrinol. Lett., 17 (1995) 173-179.
27. [27] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, Sydney.
28. 3H]MK-801 binding in rat brain, J. Neurochem., 60 (1993) 1344-1353.
29. [29] Shank, R.P. and Campbell, G., Glutamate. Neurotoxic effects of glutamate. In A. Lajtha(Ed.), Handbook of Neurochemistry, Plenum Press, New York, 1983, pp. 381-404.
30. [30] Simson, E.L., Gold, R.M., Standish, L.J. and Pellet, P.L., Axonsparing brain lesioning technique: The use of monosodium-L-glutamate and other amino acids, Science, 198 (1977) 515-517.
31. [31] Szatkawski, M. and Attwell, D., Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms, Trends Neurosci., 17 (1994) 359-365.
32. [32] Taleisnik, S., Caligaris, L. and De Olmos, J., Luteinizing hormone release by cerebral cortex stimulation in rats, Am. J. Physiol., 203 (1962) 1109.
33. [33] van den Pol, A., Wuarin, J.P. and Dudek, F.E., Glutamate, the dominant excitatory transmitter in neuroendocrine regulation, Science, 250 (1990) 1276-1278.
34. [34] Weiland, N., Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus, Endocrinology, 131 (1992) 662-668.
35. [35] Westerberg, E. and Wieloch, T.W., Changes in excitatory amino acid receptor binding in the intact and decorticated rat neostriatum following insulin-induced hypoglycemia, J. Neurochem., 52 (1989) 1340-1347.